Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science VC Funds in France

Last updated: Apr 2024 A list of 50 VC funds that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.

Top 50 Life Science VC Funds in France

Investor	Life Science France investments
Bpifrance	9
Kurma Partners	7
Omnes Capital	5
Idinvest Partners	4
Seventure Partners	4
AdBio partners	4
Paca Investissement	4
Blue Horizon Corporation	3
Advent Life Sciences	3
Sofinnova Partners	3
Boehringer Ingelheim Venture Fund	3
Galia Gestion	3
Siparex Groupe	2
Beyond Impact	2
Heartcore Capital	2
Eutopia VC	2
WiSEED	2
Karista	2
Point Nine	2
Horizons Ventures	2
Kinled Holding	2
IRDI SORIDEC Gestion	2
AQUITI Gestion	2
JDRF T1D Fund	2
Thia Ventures	2
XAnge	2
Sofimac Investment Managers	2
Partech	2
Air Street Capital	2
Angels Santé	1
Crédit Mutuel Innovation	1
Capitole Angels	1
ACG Management	1
Eternam	1
Societe Generale Asset Management	1
Capital Grand Est	1
Calao Finance	1
ADI Nouvelle-Aquitaine	1
AxLR	1
Earlybird Venture Capital	1
INRA	1
InnoBio Fund	1
Eli Lilly	1
Matignon Technologies	1
Amundi Private Equity Funds	1
Gimv	1
Credit Mutuel	1
Inserm Transfert Initiative	1
EIC-Fund	1
CELESTE	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
France, United States, Switzerland

Portfolio highlights

HawkCell — A plug-and-play solution turning human MRI into the first animal-dedicated imaging enhanced with AI algorithms. A unique MRI solution.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Docent — Docent is the first AI-powered mobile application to offer a fully-personalized experience for discovering, accessing and collecting contemporary masterpieces.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Series B, Seed
France, Spain, Switzerland

Portfolio highlights

Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Shorla Pharma — Shorla Pharma is an Irish specialty pharmaceutical company. It is growing portfolio brings accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.

Omnes, "Powering Entrepreneurs" is a Leading private equity firm dedicated to energy transition and innovation.

Investment focus

Software, Biotechnology, Health Care
Series A, Funding Round, Series B
France, United States, Belgium

Portfolio highlights

Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Investment focus

Biotechnology, Software, Health Care
Series B, Series A, Funding Round
France, United States, Spain

Portfolio highlights

Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
BreezoMeter — BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Investment focus

Biotechnology, Health Care, Software
Series A, Funding Round, Series B
France, United States, Germany

Portfolio highlights

Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Funding Round
France, Spain, Belgium

Portfolio highlights

Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
Anoat Therapeutics — Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Investment focus

Software, Internet, Manufacturing
Seed, Funding Round, Series A
France

Portfolio highlights

GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.

Our mission is to accelerate the transition to a new Sustainable Food System that delivers outstanding returns for investors and the planet.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Funding Round
United States, United Kingdom, France

Portfolio highlights

WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
New School Foods — Whole-muscle, plant-based seafood
Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
United States, United Kingdom, France

Portfolio highlights

Argá Medtech — Developing the next generation of Pulsed Field Ablation and Irreversible Electroporation Venture-capital backed company
PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Actym Therapeutics, Inc. — Actym Therapeutics is developing key biotech to help target intractable immune pathways in the tumor microenvironment.
smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Investment focus

Software, Manufacturing, Biotechnology
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Wizaly — Unlock the Power of Marketing Analytics at Wizaly.com: Optimize Your Marketing Campaigns, Maximize ROI, and Understand the Customer Journey. Discover actionable
Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Investment focus

Manufacturing, Software, Information Technology
Private Equity, Funding Round, Seed
France, United States, Italy

Portfolio highlights

E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
NeoPhotonics — NeoPhotonics design and manufacture advanced hybrid photonic integrated optoelectronic devices for ultra-fast communications networks, including optical components
Monet Associes — Monet + Associes is a public relations agency.

A trusted Microsoft Gold Partner, Beyond Impact is uniquely positioned to help manage your new cloud platform from end to end with turnkey managed services. Our Azure Managed services offer cutting-edge capabilities to address your business needs.

Investment focus

Food and Beverage, News, Seafood
Seed, Series A, Pre-Seed
France, Canada, Singapore

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.

Heartcore Capital invests in companies re-enchanting the world through technology.

Investment focus

Software, Machine Learning, Artificial Intelligence
Series A, Seed, Series B
Denmark, Germany, United States

Portfolio highlights

Quesma — At Quesma we help customers to innovate faster by re-shaping the way applications are built and connected to their DBs. Quesma database gateway enables development teams to modernise and evolve application architecture.
CarbonPool — Innovative carbon credit insurance which pays claims in carbon credits, not cash. See how we can help you.
Superform Labs — THE UNIVERSAL INTERFACE FOR YIELD IS FORMING

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

Investment focus

Retail, E-Commerce, Food and Beverage
Seed, Series A, Funding Round
France, Belgium, Denmark

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
Nous anti-gaspi — We anti-Gapsi is the network of anti-waste food stores. This grocery store project offers producers and manufacturers the opportunity to their downgraded and unsold products at a fair price. They are a qualitative environment, they market products excluded from the usual mass distribution circuits for small defects, physical defects, contract-datenot respected, and end of series. They offer consumers a new mode of consumption that gives priority to common sense and that is at the same time smart, qualitative, and eco-responsible. In their stores, they offer you to find, in a warm atmosphere, a complete choice of food products to save waste: fruits and vegetables, fresh and frozen products, groceries, and even a small bulk section.

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Investment focus

Software, Manufacturing, Biotechnology
Seed, Funding Round, Equity Crowdfunding
France

Portfolio highlights

Dianosic — Dianosic was founded in 2017 and develops innovative solutions in the field of ENT (Ear, Nose & Throat), a $50 billion, double digit growth, and still largely underserved market. Our startup operates right at the frontier between Medtech and Biotech, as we see tremendous opportunities for drug-device combinations in this specialty. The projectoriginates from the ENT Department from the University Hospital of Strasbourg, where unmet clinical needs have been identified. Our main focus areas are Chronic Rhinitis, Chronic Sinusitis and intranasal bleeding (Epistaxis). Noteworthy, Dianosic has a strong French and German footprint in R&D and manufacturing.Dianosic’s strategic goal is to establish new standards of care in Chronic Rhinitis and Chronic Sinusitis with its drug-eluting Active Resorbable Scaffold (ARIS). This drug-device combination ARIS platform, developed with world renowned resorbable polymers experts, has the potential to establish new treatment paradigms. Moreover, our ARIS platform creates immense opportunities to create other verticals, especially in the field of chronic migraine and facial pain.Beside this, Dianosic commercialize an Asymmetric Intranasal inflatable solution (CAVI-T) for the treatment of intranasal bleeding, a widespread condition in ENT that affects 10% of the population. This CE marked and FDA registered technology addresses a clear unmet need and demonstrated our ability not only to develop a differentiated technology in record time, but also to successfully transition from R&D to Sales. We are currently present in relevant markets in EU and paving the way to launch in the U.S. in the mid term. Noteworthy, since our main call point is the ENT, CAVI-T prepares the ground for our upcoming ARIS platform.
VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Series B
France, United States, Germany

Portfolio highlights

constellr — Smart Farming and Climate Monitoring from Space. At constellr, we are using cutting-edge beyond-visual imaging technology to revolutionise the way we assess crucial aspects of our planet's health.
Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

Investment focus

Software, SaaS, Internet
Seed, Series A, Series B
Germany, United States, France

Portfolio highlights

ZenML — ZenML is an extensible, open-source MLOps framework to create production-ready machine learning pipelines. Built for data scientists, it has a simple, flexible syntax, is cloud- and tool-agnostic, and has interfaces/abstractions that are catered towards ML workflows. At its core, ZenML pipelines execute ML-specific workflows from sourcing data to splitting, preprocessing, training, all the way to the evaluation of results and even serving. There are many built-in batteries to support common ML development tasks. ZenML is not here to replace the great tools that solve these individual problems. Rather, it offers an extensible framework and a standard abstraction to write and build your workflows.
Upciti — Upciti provider of precise, localized and real-time data for smart cities and smart retailers. we produce and make available data at the service of man to make cities smarter and more pleasant to live for all on a daily basis.
BlueLayer — BlueLayer transforms the management of carbon projects with a cutting-edge software stack that frees up valuable resources to bring more quality credits to market.

Investing in the deep science and technology that can propel humanity towards a radically better future.

Investment focus

Biotechnology, Artificial Intelligence, Software
Series A, Series B, Seed
United States, United Kingdom, Canada

Portfolio highlights

Xampla — Xampla: Drop-in replacements for single-use plastic, eliminating plastic pollution. Biodegrade quickly & safely. Named world's most promising cleantech co.
MioTech — MioTech is an artificial intelligence platform that empowers investment managers to better serve their clients in a world of complex data. By integrating and analyzing data from all types of sources, MioTech streamlines the entire investment process, creating an ultimate data-driven investing experience. MioTech has offices in Shanghai and HongKong.MioTech is backed by Horizons Ventures, ZhenFund, and prestigious individual investors around the world.
Cauldron Ferm — Cauldron is sustainably delivering the precision fermented prototypes of today to the supermarket shelves of tomorrow.

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Investment focus

Biotechnology, Health Care, Financial Services
Seed, Funding Round, Series A
United Kingdom, United States, Switzerland

Portfolio highlights

Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.

IRDI SORIDEC Gestion

Investment focus

Biotechnology, Information Technology, Health Care
Seed, Funding Round, Series A
France

Portfolio highlights

Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.
Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.
TOOPI Organics — TOOPI Organics is specializing in using human urine for agriculture and industry

Acteur incontournable du capital-investissement en Nouvelle-Aquitaine

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series A
France, United States

Portfolio highlights

Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.
Pony — Instant city bike hire
ALOGIA Groupe — ALOGIA Groupe offers preventive health responses to senior people at home through care management and innovative services.

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, Italy, Canada

Portfolio highlights

DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
SAB Biotherapeutics — A biopharmaceutical development company leading the science and manufacturing of antibody therapeutics. Utilizing some of the most advanced antibody science in the world, SAB is delivering the world’s first large-scale platform to create immunoglobulins. This natural production platform holds the potential for treatment of public health problems,rare conditions, long-term diseases and global pandemic threats.
Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed, Pre-Seed
United States, France, Denmark

Portfolio highlights

Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.
People Science — People Science offers data collection technology and services for clinical research studies of alternative medicines and wellness interventions.
Pow.bio — Pow.bio provides fermentation services for synthetic biology.

For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.

Investment focus

Software, SaaS, Information Technology
Series A, Seed, Series B
France, Germany, Belgium

Portfolio highlights

airfocus — airfocus is the first modular product management software: Manage and communicate your product strategy, prioritize your roadmap, and solve the right problems.
Vertuoza — Developed by and for professionals, Vertuoza construction software makes your life easier and allows you to focus on the essentials of your business. With a single click, you can edit estimates, work schedules, site follow-up and invoicing, wherever you are.Much more than a software Vertuoza is inspired by the words "virtuous" and"virtuose" both in its name and in its philosophy. It's more than just a construction software or a site management application: it's the key to a perfect fit between the different elements of your business.What's more, Vertuoza is a win-win situation. The contractor gains time and efficiency, the client benefits from better service and the architect sees his project in the spotlight.
Sirona Technologies — Pioneering direct air capture (DAC) technology with a focus on speed, scalability and a low capex design.

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
France, Italy, Austria

Portfolio highlights

Blue Valet — Blue Valet is a provider of valet parking-parking at airports and train stations.
Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Investment focus

Software, E-Commerce, Financial Services
Series A, Seed, Series B
United States, France, Germany

Portfolio highlights

Groover — Groover is the best way to promote your music to blogs, radios, record labels, & Spotify playlisters. Get listened to, receive coverage & guaranteed feedback!
HD — HD is a healthcare and surgery marketplace, powering over 1,500+ healthcare providers including some of the biggest hospitals. HD connects patients to hospitals, clinics, operating rooms, and surgeons while offering healthcare financing solutions to increase access to affordable care and surgeries. To date, over 250,000 patients have benefited frommore accessible and affordable healthcare and surgeries through the company's platform.
MyRealTrip — MyRealTrip is leading tours&activities marketplace in South Korea. MyRealTrip is the best free travel platform in Korea where you can book flights, accommodations, tours & tickets, and special offers. Starting with guided tour service in 2012, it has been growing rapidly since it successfully launched air service in 2018. MyRealTrip isconstantly striving to provide travelers with a personalized experience and provide them with a more valuable experience.

Air Street Capital invests in AI-first technology and life science companies.

Investment focus

Artificial Intelligence, Machine Learning, Biotechnology
Seed, Series A, Pre-Seed
United States, Canada, France

Portfolio highlights

CellVoyant — We provide services to accelerate development of stem cell therapies. We make therapy development faster and more cost-effective.
Lambda Automata — Building the digital backbone for the age of autonomous warfare.
Interloom Technologies — Interloom offers AI-driven process automation for enterprises to maximize organizational efficiency and accuracy.

Angels Santé is a networking site for investors and companies in the health sector.

Investment focus

Health Care, Medical Device, Biotechnology
Seed, Funding Round, Angel
France, India, United States

Portfolio highlights

Abcely — Abcely is a biotech firm that is working on a novel anti-cancer medication.
Odimma — Empowering personalized immunotherapy to treat cancer
SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Series A, Series B
France, United States, Canada

Portfolio highlights

Quandela — Quandela is an expert in the fabrication of performing devices for the research in quantum photonics and quantum information. They fabricate unique solid-state sources of quantum light. These sources bring a new revolution in quantum technologies based on light.The company's single-photon source device combines photonics and semiconductorquantum dots for quantum communication, computation and sensing and permits to collect the emitted single-photons with exceptional efficiency at high rates, enabling researchers to strongly reduce the charge noise decoherence and assist in the emission of identical photons with fidelity close to unity, an essential requirement for the development of the most advanced quantum applications.
HarfangLab — HarfangLab develops a hunting software to boost detection and neutralization of cyberattacks against companies endpoints. They plug their platform to third-party cybersecurity solutions to enhance visibility on your system. Their specialists have led many operations of defensive and offensive cyberwarfare for ANSSI (the French National Agency forthe Security of Information Systems), the French ministry of Defense and major cybersecurity companies.
Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.

Capitole Angels is to create this association was born from the experience of many of its founders in the field of start-ups including the following observations. Need a structure enabling them to meet investors / promoters of the project. Plethora of potential investors hampered by the lack of an open structure. A region rich in technology,its universities, laboratories and therefore the bearer of innovation.

Investment focus

Information Technology, Software, 3D Technology
Seed, Angel, Funding Round
France

Portfolio highlights

EPUR — EPUR has developed the OAKBOT, a portable digital milling machine for traditional woodwork and wood construction.
Sensivic — Designed and manufactured in France, SENSIVIC smart audio detection systems add meaning to your security. Our solutions automatically detect and alert you in real time as soon as an abnormal sound or suspicious noise occurs.
La Fabrique à Innovations — La Fabrique à Innovations provides a collaborative platform to transform innovative ideas into real products.

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Investment focus

Software, Health Care, Biotechnology
Funding Round, Seed, Series A
France, Madagascar

Portfolio highlights

Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.

Eternam engages in business throughout the commercial real estate value chain, including investments in residential plots, club deals, SCPI allocation guidance, and real estate investment funds. They are specialists in club negotiations, capital invested in real estate, and the structuring of company real estate operations. Along with propertyadvisory services, they provide real estate investment and property management services.

Investment focus

Health Care, Life Science, Clinical Trials
Series A
France

Portfolio highlights

DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Investment focus

Biotechnology, Software, Health Care
Series B, Funding Round, Series A
France, United States, Germany

Portfolio highlights

Augure — Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence inthe media and on social networks.The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies.Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.

Capital Grand Est is a private equity firm that focuses on supporting businesses. Capital Grand Est was founded in 2012 and was headquartered in Schiltigheim, France.

Investment focus

Health Care, Biotechnology, Computer
Funding Round, Seed, Series A
France

Portfolio highlights

Odimma — Empowering personalized immunotherapy to treat cancer
Braintale — Braintale develops and distributes accessible and effective diagnosis and prognosis tools for brain-injured patients.BrainTale’s products are based on medical needs understanding, fulfilling healthcare professionals and patients’ expectations, and is built upon more than 15 years of clinical development. The company was founded in 2018 and basedin Paris, France.
Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.

CALAO Finance is an independent private equity company, specialized in financing European SME.

Investment focus

Information Technology, Software, Big Data
Funding Round, Series A, Series B
France, United States

Portfolio highlights

ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
Kalray — DPU processors, accelerator cards, software-defined storage and data management solutions for high-performance, data-centric computing.
ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .

ADI Nouvelle-Aquitaine is a non-profit organization that renders fundraising, strategy, innovation management, and support services.

Investment focus

Life Science, Biotechnology, Waste Management
Seed
France

Portfolio highlights

Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.

AxLR specializes in the assistance of commercialization and academic research maturity-based innovative projects.

Investment focus

Life Science, Biotechnology
Pre-Seed
France

Portfolio highlights

Ingraalys — Ingraalys studies genomic and cellular plasticity during development and aging. Exploring the limitations of this plasticity prompted her to investigate the potential reversibility of cellular aging.

Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.

Investment focus

Software, Information Technology, Health Care
Series A, Seed, Series B
Germany, United States, United Kingdom

Portfolio highlights

Flanks — Flanks can automate up to 80% of the manual processes performed by wealth managers. Automate and democratize your financial services with us now.
Upvest — Upvest empowers financial institutions to offer investment products in their app with a modular, scalable, and accessible API. Upvest brings together everything that’s required to offer a broad range of investment products on the website and app. They are connected to the world’s leading asset providers and exchanges to provide the bestinvestments, at the best prices and execution speed.
Nortech AI — Nortech AI: Plug-and-play Industrial IoT for data collection & performance management. Shift from reactive to proactive savings with step-by-step digitalization | Nortech

INRA is Europe’s top agricultural research institute and the world’s number two centre for the agricultural sciences. Its scientists are working towards solutions for society’s major challenges.

Investment focus

Biopharma, Health Care, Biotechnology
Seed, Series A
France

Portfolio highlights

ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.

InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in thehealthcare market.

Investment focus

Biotechnology, Therapeutics, Health Care
Funding Round, Series A, Series C
France, United States

Portfolio highlights

Advicenne — Specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan renal diseases and neurology.
Millendo Therapeutics — Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.
Pixium Vision — Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that forblind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2.Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.

Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It alsoconducts research to find products to treat diseases in animals and to increase the efficiency of animal food production. Products Neurosciences products, include Zyprexa, for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; Cymbalta, for the treatment of the major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, and in the United States for the management of fibromyalgia; Strattera, for the treatment of attention-deficit hyperactivity disorder in children, adolescents, and adults; Prozac, for the treatment of the major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and Symbyax, for the treatment of bipolar depression. Endocrinology products, include Humalog, Humalog Mix 75/25, and Humalog Mix 50/50tm, for the treatment of diabetes; Humulin, for the treatment of diabetes; Byetta, for the treatment of type 2 diabetes; Actos, for the treatment of type 2 diabetes; Evista, for the prevention and treatment of osteoporosis in postmenopausal women and for the reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer; Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture; and Humatrope, for the treatment of human growth hormone deficiency and idiopathic short stature.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Funding Round
United States, United Kingdom, China

Portfolio highlights

OrsoBio — Developing first-in-class therapies to treat patients with metabolic disorders including diabetes, severe dyslipidemias, and more.
UpDoc — UpDoc is a technology-enabled services firm that offers the world's first unique conversational AI platform for autonomous prescription management.
Firefly Bio — Firefly specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.

Matignon Technologies is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies specialized in high technologies with strong growth potential. The Fund invests as a minority shareholder with a stake comprised between euro 0.5 M and 3.0 M euro. Subscriptions were closed in September 2000and the Fund has a lifespan of six years.

Investment focus

Medical, Biotechnology, Medical Device
Series A, Series B, Funding Round
United States, France

Portfolio highlights

Gentis — Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine. The company's patented product is DiscCell, an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc.Gentis wasfounded on 2000 and is headquartered in Wayne, Pennsylvania.
Alveolus — Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.
Arterial Remodeling Technologies — Arterial Remodeling Technologies SA engages in developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. The company was founded in 2002 and is based in Noisy le Roi, France.

Amundi Private Equity Funds, an Amundi asset management subsidiary, specialises in private equity and unlisted infrastructure investments. Combining a wealth of expertise in all aspects of asset management built up over more than 10 years, Amundi provides both institutional and individual investors with a wide spectrum of investmentopportunities, ranging from direct fund investments in unlisted French and foreign companies to dedicated mandates and funds-of-funds for multi-management private equity and infrastructure investments. With more than 60 professionals based in Paris, Bucharest, Cairo, Casablanca, Tunis and Warsaw, Amundi Private Equity Funds assists companies at all stages of their development, the key objective being to offer fund subscribers yields in line with the best in the industry. At 31 December 2009, French and international subscribers had committed more than â‚¬3.7 billion to Amundi Private Equity Funds, making it a leading private equity player. The company owes its solid foundations to its positioning as part of a leading third-party asset management group of companies and to its membership of two international banking groups.

Investment focus

Software, E-Commerce, Biotechnology
Funding Round, Private Equity, Series A
France, India, Hungary

Portfolio highlights

Vivalto Vie — Vivalto Vie is a privately held company that operates retirement homes in the Poitou-Charentes and Pays de la Loire regions.
Airtel — Bharti Airtel Limited, commonly known as Airtel, is an Indian multinational telecommunications services company headquartered in New Delhi, India. It operates in 20 countries across South Asia, Africa, and the Channel Islands. Airtel has a GSM network in all countries in which it operates, providing 2G, 3G and 4G services depending upon the countryof operation.Airtel is the largest provider of mobile telephony and second largest provider of fixed telephony in India, and is also a provider of broadband and subscription television services. It offers its telecom services under the "airtel" brand, and is headed by Sunil Bharti Mittal. Bharti Airtel is the first Indian telecom service provider to achieve Cisco Gold certification. It also acts as a carrier for national and international long distance communication services. The company has a submarine cable landing station at Chennai, which connects the submarine cable connecting Chennai and Singapore.
Les Opticiens Mobiles — Les Opticiens Mobiles is the first national network of opticians trained to intervene everywhere : at home, at work or in nursing homes or residences for elderly, both for working people and for fragile, isolated people.Covering the whole territory, the health professionals come to visit you with all the equipment needed. Based on an ethic chart,they offer services and products tailored to all : all types of glasses (eyeglasses, sunglasses, safety googles, contact lenses, hearing protection) with fixed prices, reimbursed by social welfare.

Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.

Investment focus

Biotechnology, Health Care, Medical
Series B, Funding Round, Private Equity
Belgium, United States, France

Portfolio highlights

ERS — ERS is a semiconductor manufacturing company that offers thermal wafer testing and Air-Cool technology services.
Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is

Credit Mutuel is a French investment bank specialized in early stage venture investments.

Investment focus

Finance, Financial Services, E-Commerce
Funding Round, Seed, Series A
France

Portfolio highlights

Vinidaily — Vinidaily is the application that helps you choose the wine 100% adapted to your tastes and the occasion, in your favorite supermarket and soon everywhere else.
EuraTechnologies — EuraTechnologies promotes economic and social development through the exchange of scientific research and technologies. It is founded upon a principle of “technopolis”- a place dedicated to creating a vibrant synergy among research, superior education and technology.
Meccellis Biotech — Meccellis Biotech is a manufacturer of tissue and cell and biomaterials.

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about â‚¬4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Investment focus

Biotechnology, Medical, Health Care
Series A, Series B, Seed
France, Switzerland, United States

Portfolio highlights

Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
VectivBio — We Are Ironwood
Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.

EIC offers investors the opportunity to co-invest in the most innovative start-ups and SMEs in the EU

Investment focus

Information Technology, Health Care, Software
Seed, Grant, Series A
France, Turkey

Portfolio highlights

EyeLights — EyeLights is a Head Up Display GPS. It allows motobikers to truly experience the ride by keeping their eyes on the road. Eyelights is the first universal motorcycle accessory that projects guidance, danger zones and traffic directly into your field of vision. A dangerous bend, a nearby stopper or speed over limitations, EyeLights warns you. Simple,uncluttered, they adapted the display for motorcycle riding.The EyeLights product installs in less than 5 minutes on your full-face, convertible or jet helmet. Their compact optical technology allows you to view your GPS more than 2 meters away while enjoying audio functions for more than 8 hours. The product is compatible with sun visors, insensitive to rain or fog and weighs less than 100g.
Mistikist — Mistikist's AI Assisted Brainwave Entrainment for focus, relaxation & sleep. Well-being in just minutes with neuroscience backed methodology.
Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.

CELESTE operates as an Internet provider for different companies. The company offers a range of solutions which covers Internet access, MPLS interconnection and fiber optics, IP telephony or ecological data center hosting. CELESTE was founded in 2001 and is headquartered in Champs-sur-marne, Ile-de-France.

Investment focus

Portfolio highlights

DocCity — DocCity LifeSciences creates and provides outstanding spaces to house cutting-edge healthcare businesses. DocCity provides clinicians with state-of-the-art, fully furnished health spaces with roomy, well-lit, and digitally equipped consultation rooms and reception areas.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate